相关实验视频

Updated: Aug 23, 2025

Cell-based Assay to Study Antibody-mediated Tau Clearance by Microglia

Cell-based Assay to Study Antibody-mediated Tau Clearance by Microglia

Published on: November 9, 2018

TREM2通过SYK依赖和独立的途径驱动微质对粉样β的反应

Shoutang Wang¹, Raki Sudan¹, Vincent Peng¹

¹Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA.

|October 28, 2022

概括

阿尔茨海默病 (AD) 涉及小质细胞. SYK通路对于微质清除粉样质斑块至关重要,其缺乏会加速AD病理. 通过CLEC7A激活SYK可能为AD提供新的治疗选择.

科学领域:

神经科学
免疫学
遗传学

背景情况:

微质在阿尔茨海默病 (AD) 发病过程中起着关键作用.
与疾病相关的微质 (DAM) 具有特定的转录特征,通常与TREM2-DAP12-SYK通路相关.
这种TREM2 R47H变体通过SYK损害微质激活增加了AD风险.

研究的目的:

研究SYK在AD中对粉样β (Aβ) 斑块的微质反应中的作用.
阐明参与微细胞激活和DAM形成的信号通路.
探索针对SYK的潜在治疗策略.

主要方法:

使用SYK缺陷的微细胞模型来评估它们对Aβ的反应.
在SYK缺乏的微质中分析PI3K-AKT-GSK-3β-mTOR通路.
研究了DAP10适配蛋白在TREM2信号传递中的作用.
向TREM2 R47H变体小鼠注射CLEC7A抗体以评估治疗疗效.

主要成果:

缺少SYK的小质细胞未能封闭Aβ斑块,导致加速的大脑病理和行为缺陷.
SYK 缺乏破坏了 PI3K- AKT- GSK-3β- mTOR 途径,阻碍了 DAM 概况的发展.
尽管SYK缺乏,但微细胞通过DAP10途径增殖并达到前性DAM阶段.
在TREM2 R47H小鼠中通过CLEC7A拯救微质激活SYK的抗体介导激活.

结论:

微质Aβ反应涉及不同的,非冗余的SYK和DAP10信号通路.
SYK对于有效管理Aβ病理和预防加速神经退行至关重要.
针对SYK激活,可能通过CLEC7A,为阿尔茨海默病提供了一个有前途的治疗途径.

关键词:

阿尔茨海默病美国没有.其他:没有了其他:免疫疗法代谢过程微质细胞信号传输

更多相关视频

Author Spotlight: In Vitro Co-Culture Model for Studying Microglia-Neuronal Interactions in Disease Conditions

Author Spotlight: In Vitro Co-Culture Model for Studying Microglia-Neuronal Interactions in Disease Conditions

Published on: July 26, 2024

Isolation of Cortical Microglia with Preserved Immunophenotype and Functionality From Murine Neonates

Isolation of Cortical Microglia with Preserved Immunophenotype and Functionality From Murine Neonates

Published on: January 30, 2014

相关概念视频

Enzyme-linked Receptors

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...

Amyloid Fibrils

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...